On ECHEMI
Home > Drugs > Shandong XinYi Pharmaceutical Co., Ltd.
Shandong XinYi Pharmaceutical Co., Ltd.
  • Founded in:

    2013-04-09
  • Country:

    China China
  • Address:

    No. 1 Xingping Road, Pingyuan County
  • Tax NO.:

    91371426065926234K
  • Registered Funds:

    177.40615851 million yuan
  • Website:

  • Email:

Related Drugs
Artificial Bezoar Metronidazole Capsules
This product is a compound preparation, each tablet contains 0.2g of metronidazole and 5mg of artificial bezoar.
Name Description Content CAS NO. Registered Holders
Metronidazole

It has a strong antibacterial effect on most anaerobic bacteria. The bactericidal mechanism has not been fully elucidated. The nitroreductase of anaerobic bacteria plays an important role in the energy metabolism of sensitive strains. The nitro group of this product is reduced to a cytotoxin, thereby acting on the DNA metabolism process of the cell and promoting the death of bacteria.

More

It has a strong antibacterial effect on most anaerobic bacteria. The bactericidal mechanism has not been fully elucidated. The nitroreductase of anaerobic bacteria plays an important role in the energy metabolism of sensitive strains. The nitro group of this product is reduced to a cytotoxin, thereby acting on the DNA metabolism process of the cell and promoting the death of bacteria.

0.2g 443-48-1 39
Atificial Cow-bezoar

Antipyretic and anti-inflammatory effects

More

Antipyretic and anti-inflammatory effects

5mg 1002-00-2 2
Telmisartan
Name Description Content CAS NO. Registered Holders
Telmisartan

No specific description provided

More

No specific description provided

144701-48-4 109
Carbocisteine Tablets
The main ingredient of this product is carbocysteine. Its chemical name is: S-(carboxymethyl)-cysteine. Molecular formula: C5H9NO4S Molecular weight: 179.19
Name Description Content CAS NO. Registered Holders
S-Carboxymethyl-L-cysteine

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

2387-59-9 13
Losartan Potassium and Hydrochlorothiazide Tablets
This product is a compound preparation, and its components are: each tablet contains 50 mg of losartan potassium and 12.5 mg of hydrochlorothiazide.
Name Description Content CAS NO. Registered Holders
Losartan potassium

Angiotensin II receptor (AT1 receptor) antagonist, blocks all physiological effects related to angiotensin II, lowers blood pressure, inhibits aldosterone release, reduces proteinuria, maintains glomerular filtration rate, and lowers blood uric acid.

More

Angiotensin II receptor (AT1 receptor) antagonist, blocks all physiological effects related to angiotensin II, lowers blood pressure, inhibits aldosterone release, reduces proteinuria, maintains glomerular filtration rate, and lowers blood uric acid.

50mg 124750-99-8 69
Hydrochlorothiazide

Diuretics and antihypertensive drugs affect the reabsorption of electrolytes in the distal renal tubules, increase the excretion of sodium, chloride, potassium and bicarbonate, and have diuretic and antihypertensive effects.

More

Diuretics and antihypertensive drugs affect the reabsorption of electrolytes in the distal renal tubules, increase the excretion of sodium, chloride, potassium and bicarbonate, and have diuretic and antihypertensive effects.

12.5mg 58-93-5 56
Ozagre
Name Description Content CAS NO. Registered Holders
Ozagrel

82571-53-7 29
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.